Who has invested in Rampart Bioscience?

OrbiMed are named among the investors backing Rampart Bioscience.

Rampart Bioscience Funding: $125M Raised, Series A (2023)

Rampart Bioscience funding overview

Rampart Bioscience is based in La Jolla, California. Rampart Bioscience has raised $125M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in October 2023. The round record for Rampart Bioscience runs through 2023; nothing later has been disclosed. Investors on record include OrbiMed.

Rampart Bioscience at a glance

Total raised: $125M
Latest round: Series A
Latest round date: October 2023
Headquarters: La Jolla, California
Notable investors: OrbiMed

Frequently asked about Rampart Bioscience funding

How much has Rampart Bioscience raised?: Rampart Bioscience has raised $125M in total disclosed funding across the rounds on record.
Who has invested in Rampart Bioscience?: OrbiMed are named among the investors backing Rampart Bioscience.
What was the latest Rampart Bioscience funding round?: The most recent disclosed round is a Series A, announced in October 2023.
Where is Rampart Bioscience based?: Rampart Bioscience is based in La Jolla, California.
When did Rampart Bioscience last raise?: The last disclosed Rampart Bioscience round closed in October 2023 at Series A.

Rampart Bioscience totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in La Jolla below to benchmark round size and investor mix.

Rampart Bioscience Funding: $125M Raised, Series A (2023)

Rampart Bioscience funding overview

Rampart Bioscience at a glance

Frequently asked about Rampart Bioscience funding

Companies related to Rampart Bioscience (28)

Browse related funding lists (3)